No Data
No Data
Biogen Stock Touches 52-week Low at $183.55 Amid Market Challenges
Scholar Rock Stock Quadruples on Positive Trial Data -- Barrons.com
Scholar Rock's Muscle Wasting Drug Excels In Pivotal Trial, Plans FDA Submission Next Year
Why Biogen Inc. (BIIB) Is a Top Value Stock for the Long-Term
Barclays Initiates Biogen(BIIB.US) With Hold Rating, Announces Target Price $190
Analysts Offer Insights on Healthcare Companies: Pfizer (PFE) and Biogen (BIIB)
No Data
No Data
webguybob : The Etsy downgrade surprised me!
105535782 : ok
102242135 Lim : K